Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Venkata Narayana Active Ingredients (VNAI) is an Indian pharmaceutical company specializing in the development and large-scale manufacturing of Active Pharmaceutical Ingredients (APIs) and advanced drug intermediates. Established in 2015 and headquartered in Nellore, Andhra Pradesh, the company operates state-of-the-art manufacturing facilities that comply with international quality standards, including Good Manufacturing Practices (GMP). VNAI serves as a Contract Development and Manufacturing Organization (CDMO), providing chemical synthesis and process development services to global pharmaceutical partners. Their product portfolio primarily focuses on small molecule therapeutics across diverse categories such as anti-diabetics, cardiovascular agents, and central nervous system treatments. The company is recognized for its technical expertise in complex chemical synthesis and its commitment to providing cost-effective solutions for the global generic drug market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Venkata Narayana Active Ingredients.